Roberto Salvatori Selected Research

Pituitary Dwarfism

4/2022	Art and science: impact of semioccluded vocal tract exercises and choral singing on quality of life in subjects with congenital GH deficiency.
1/2022	Dental arches in inherited severe isolated growth hormone deficiency.
1/2021	Disruption of the GHRH receptor and its impact on children and adults: The Itabaianinha syndrome.
1/2021	Circulating microRNA profile in humans and mice with congenital GH deficiency.
1/2021	Formant Frequencies, Cephalometric Measures, and Pharyngeal Airway Width in Adults With Congenital, Isolated, and Untreated Growth Hormone Deficiency.
1/2021	Reduced fibroblast growth factor 21 and β-Klotho secretion in untreated congenital isolated GH deficiency.
11/2020	Cerebral vasoreactivity, a surrogate marker of cerebrovascular disease, is not impaired in subjects with lifetime, untreated, congenital isolated GH deficiency.
1/2020	Vestibular function in severe GH deficiency due to an inactivating mutation in the GH-releasing hormone receptor gene.
4/2019	Walking and postural balance in adults with severe short stature due to isolated GH deficiency.
1/2019	Enteroendocrine Connections in Congenital Isolated GH Deficiency Due to a GHRH Receptor Gene Mutation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Salvatori Research Topics

Disease

40	Pituitary Dwarfism 04/2022 - 03/2002
26	Neoplasms (Cancer) 01/2022 - 05/2005
16	Acromegaly 06/2022 - 05/2005
14	Pituitary Neoplasms (Pituitary Adenoma) 03/2022 - 05/2005
12	Cushing Syndrome 02/2021 - 11/2006
11	Prolactinoma (Prolactinomas) 03/2022 - 07/2009
11	Insulin Resistance 01/2019 - 05/2002
11	Adenoma (Adenomas) 01/2018 - 07/2009
7	Pituitary ACTH Hypersecretion 12/2021 - 04/2010
7	Hypopituitarism (Sheehan's Syndrome) 11/2020 - 07/2009
7	Atherosclerosis 11/2020 - 06/2006
7	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2020 - 04/2013
6	Hypophysitis 01/2019 - 12/2011
4	Melanoma (Melanoma, Malignant) 01/2016 - 01/2012
3	Hyperprolactinemia 03/2022 - 10/2014
3	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2022 - 02/2015
3	Infections 01/2021 - 10/2016
3	Abdominal Obesity 01/2021 - 06/2006
3	Atrophy 01/2018 - 10/2016
3	Hypothyroidism 01/2018 - 12/2012
3	Pituitary Diseases (Disease, Anterior Pituitary) 05/2014 - 08/2009
2	Endocrine System Diseases (Endocrine Diseases) 01/2022 - 04/2013
2	Exanthema (Rash) 01/2021 - 04/2013
2	Facies 01/2021 - 08/2017
2	Inflammation (Inflammations) 01/2020 - 10/2019
2	Pain (Aches) 10/2019 - 11/2005
2	Pheochromocytoma 01/2019 - 03/2016
2	Leishmaniasis 01/2019 - 10/2016
2	Lymphopenia (Lymphocytopenia) 01/2018 - 01/2018
2	Genu Valgum 08/2017 - 11/2013
2	Peripheral Nerve Injuries 10/2016 - 06/2016
2	Thyroiditis 01/2016 - 05/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2015 - 05/2014
2	Brain Neoplasms (Brain Tumor) 12/2013 - 01/2012
2	Body Weight (Weight, Body) 12/2013 - 04/2009
2	Rare Diseases (Rare Disease) 12/2013 - 01/2012
2	Type IB Isolated Growth Hormone Deficiency 07/2009 - 11/2002
1	Bradycardia 01/2021
1	Ectopic ACTH Syndrome 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

30	somatotropin releasing hormone receptorIBA 04/2022 - 03/2002
23	Hormones (Hormone)IBA 01/2022 - 07/2002
22	Growth Hormone (Somatotropin)IBA 01/2022 - 05/2005
15	Insulin-Like Growth Factor I (IGF-1)IBA 06/2022 - 06/2007
10	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2021 - 07/2004
9	ProlactinIBA 03/2022 - 04/2010
9	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 11/2006
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2002
7	GlucocorticoidsIBA 01/2020 - 12/2011
7	lanreotide (Somatuline)FDA Link 01/2018 - 07/2009
7	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2017 - 05/2005
6	Dopamine Agonists (Dopamine Agonist)IBA 03/2022 - 07/2009
6	AntibodiesIBA 01/2021 - 12/2011
6	Insulin (Novolin)FDA Link 01/2018 - 05/2002
5	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2013
4	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018 - 11/2006
4	Octreotide (Sandostatin)FDA LinkGeneric 01/2018 - 07/2009
4	Proteins (Proteins, Gene)FDA Link 09/2017 - 03/2002
4	IpilimumabIBA 01/2016 - 01/2012
3	LDL CholesterolIBA 11/2020 - 06/2006
3	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 01/2020 - 09/2004
3	Pharmaceutical PreparationsIBA 11/2019 - 03/2011
3	LigandsIBA 01/2018 - 01/2009
3	aryl hydrocarbon receptor-interacting proteinIBA 09/2017 - 12/2012
3	C-Reactive ProteinIBA 08/2017 - 06/2006
3	Cabergoline FDA LinkGeneric 10/2014 - 07/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 11/2002
2	pegvisomant FDA LinkGeneric 06/2022 - 08/2021
2	amsonic acid (DAS)IBA 03/2022 - 12/2014
2	Dextrans (Dextran)FDA Link 01/2020 - 10/2019
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 10/2019
2	Ketoconazole (Nizoral)FDA LinkGeneric 11/2019 - 03/2017
2	CatecholaminesIBA 01/2019 - 03/2016
2	pasireotideIBA 01/2018 - 01/2018
2	Insulin-Like PeptidesIBA 01/2018 - 05/2005
2	Retinaldehyde (Retinal)IBA 08/2017 - 10/2016
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 09/2016 - 02/2015
2	Immune Checkpoint ProteinsIBA 01/2016 - 04/2013
2	NivolumabIBA 01/2016 - 12/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 01/2015
2	Thyroid HormonesIBA 02/2015 - 12/2012
2	Messenger RNA (mRNA)IBA 02/2015 - 07/2009
2	SteroidsIBA 01/2015 - 08/2013
2	tremelimumabIBA 12/2013 - 04/2013
2	AdipokinesIBA 12/2013 - 02/2010
2	AntigensIBA 04/2013 - 12/2011
2	Bromocriptine (Parlodel)FDA LinkGeneric 03/2011 - 07/2009
1	Dopamine Agents (Dopaminergic Agents)IBA 03/2022
1	DiureticsIBA 01/2022
1	Growth Factor ReceptorsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Lapatinib (GW572016)FDA Link 01/2021
1	fibroblast growth factor 21IBA 01/2021
1	Pituitary HormonesIBA 01/2021
1	Aligeron (AS 2)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021

Therapy/Procedure

23	Therapeutics 03/2022 - 08/2008
11	Radiotherapy 12/2021 - 05/2005
3	Adrenalectomy 03/2017 - 07/2009